Sign Out
Tablet: Hypersensitivity to deferiprone or to any of the excipients of Ferriprox. History of recurrent episodes of neutropenia; history of agranulocytosis.
Due to the unknown mechanism of deferiprone-induced neutropenia, patients should not take medicinal products known to be associated with neutropenia or those that can cause agranulocytosis (see Precautions: Tablet).
Oral Solution: FERRIPROX is contraindicated in patients with known hypersensitivity to deferiprone or to any of the excipients in the formulation. The following reactions have been reported in association with the administration of deferiprone: Henoch-Schönlein purpura; urticaria; and periorbital edema with skin rash (see Adverse Reactions: Oral Solution).
